** = Publikationen gelistet in SCI/SSCI/Pubmed
** Wurm, S; Waltersdorfer, M; Loindl, S; Moritz, JM; Herzog, SA; Bachmaier, G; Berghold, A; Kashofer, K; Beham-Schmid, C; Hoefler, G; Greinix, HT; Wölfler, A; Reinisch, A; Sill, H; Zebisch, A
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.
Wien Klin Wochenschr. 2024;
Doi: 10.1007/s00508-024-02463-w
Web of Science
PubMed
FullText
FullText_MUG
** Moritz, J; Schwab, A; Reinisch, A; Zebisch, A; Sill, H; Wölfler, A
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions.
Biomedicines. 2024; 12(3): 599
Doi: 10.3390/biomedicines12030599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dutta, S; Moritz, J; Pregartner, G; Thallinger, GG; Brandstätter, I; Lind, K; Rezania, S; Lyssy, F; Reinisch, A; Zebisch, A; Berghold, A; Wölfler, A; Sill, H
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations.
Ann Hematol. 2022; 101(4):837-846
Doi: 10.1007/s00277-022-04766-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M
Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638.
Doi: 10.21873/invivo.12209
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG